63629-4014
Ondansetron
Ondansetron
TABLET, ORALLY DISINTEGRATING
Oral
Ondansetron
4.0
mg/1
63629-4014-00
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-0)
Nov. 1, 2012

63629-4014-01
10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-1)
May 29, 2009

63629-4014-02
15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-2)
Dec. 12, 2013

63629-4014-03
20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-3)
May 18, 2010

63629-4014-04
5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-4)
Nov. 10, 2010

63629-4014-05
3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-5)
Aug. 12, 2011

63629-4014-06
14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-6)
Dec. 22, 2021

63629-4014-07
60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-7)
March 20, 2013

63629-4014-08
9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-8)
Aug. 1, 2012

63629-4014-09
6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63629-4014-9)
Aug. 9, 2012
Ancillary Therapy
Antiemetic
5HT3 Receptor Antagonist
 
 
In Use